Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionWalleye Capital LLC
Latest Disclosed Ownership2,309 shares
Latest Disclosed Value $ 69,547
Walleye Capital LLC ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 2,309 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $69,547 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 0 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). The current value of the position is $75,804 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 148,500 of underlying shares valued at $4,472,820 USD and put options representing 59,600 of underlying shares valued at $1,795,152 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,309 2,309 70 0.0003
2026-05-08 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,309 2,309 70 0.0003
2026-02-13 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -69,150 -100.00 0 -100.00
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 69,150 -72,041 -51.02 1,397 -41.00 0.0052
2025-08-13 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 141,191 -122,066 -46.37 2,366 -41.52 0.0092
2025-05-14 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 263,257 -745,626 -73.91 4,046 -81.80 0.0183
2025-02-13 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,008,883 -94,177 -8.54 22,236 11.86 0.0543
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,103,060 949,026 616.11 19,877 694.13 0.0414
2024-08-14 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 154,034 152,639 10,941.86 2,503 13,073.68 0.0045
2024-05-15 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,395 -225,056 -99.38 20 -99.20 0.0000
2024-02-14 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 226,451 187,581 482.59 2,364 496.97 0.0050
2023-11-21 2023-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 38,870 38,870 396 0.0010
2020-05-15 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -13,752 -100.00 0 -100.00
2020-02-14 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 13,752 -136,318 -90.84 135 -86.93 0.0088
2019-11-14 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 150,070 150,070 1,033 0.0615
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -16,218 -100.00 0 -100.00
2019-08-14 2019-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 16,218 16,218 254 0.0418
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 16,218 254
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 148,500 -58.44 4,473 -59.90 n/a n/a n/a
2026-05-08 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 148,500 4,473 n/a n/a n/a
2026-02-13 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 357,300 256.23 11,151 450.39 n/a n/a n/a
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 100,300 -7.73 2,026 11.26 n/a n/a n/a
2025-08-13 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 108,700 -16.83 1,822 -9.31 n/a n/a n/a
2025-05-14 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 130,700 -72.51 2,009 -80.83 n/a n/a n/a
2025-02-13 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 475,400 29.82 10,478 58.79 n/a n/a n/a
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 366,200 156.26 6,599 184.15 n/a n/a n/a
2024-08-14 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 142,900 104.43 2,322 135.50 n/a n/a n/a
2024-05-15 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 69,900 186.48 986 288.19 n/a n/a n/a
2024-02-14 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 24,400 132.38 255 137.38 n/a n/a n/a
2023-11-21 2023-09-30 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 10,500 72.13 107 137.78 n/a n/a n/a
2023-11-14 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 10,500 107 n/a n/a n/a
2023-08-14 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 6,100 46 n/a n/a n/a
2023-02-14 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 43,800 353 n/a n/a n/a
2020-05-15 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 219,800 -44.13 2,154 -20.43 n/a n/a n/a
2019-11-14 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 393,400 878.61 2,707 629.65 n/a n/a n/a
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 40,200 -36.69 371 -62.75 n/a n/a n/a
2019-08-14 2019-03-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 63,500 996 n/a n/a n/a
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 63,500 996 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 59,600 -79.97 1,795 -80.67 n/a n/a n/a
2026-05-08 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 59,600 1,795 n/a n/a n/a
2026-02-13 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 297,500 18.38 9,285 82.90 n/a n/a n/a
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 251,300 78.99 5,076 115.72 n/a n/a n/a
2025-08-13 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 140,400 -17.94 2,353 -10.50 n/a n/a n/a
2025-05-14 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 171,100 -61.47 2,630 -73.14 n/a n/a n/a
2025-02-13 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 444,100 16.65 9,788 42.67 n/a n/a n/a
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 380,700 38.03 6,860 53.09 n/a n/a n/a
2024-08-14 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 275,800 235.12 4,482 285.96 n/a n/a n/a
2024-05-15 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 82,300 -48.95 1,161 -30.98 n/a n/a n/a
2024-02-14 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 161,200 104.83 1,683 109.73 n/a n/a n/a
2023-11-21 2023-09-30 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 78,700 572.65 803 811.36 n/a n/a n/a
2023-11-14 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 78,700 803 n/a n/a n/a
2023-08-14 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 11,700 88 n/a n/a n/a
2023-02-14 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 200 2 n/a n/a n/a
2020-05-15 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 175,000 -24.01 1,715 8.27 n/a n/a n/a
2019-11-14 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 230,300 230,200.00 1,584 158,300.00 n/a n/a n/a
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 100 -99.75 1 -99.84 n/a n/a n/a
2019-08-14 2019-03-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 39,500 619 n/a n/a n/a
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 39,500 619 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.